-+ 0.00%
-+ 0.00%
-+ 0.00%

NRX Pharmaceuticals Q4 EPS $0.20 Up From $(0.77) YoY, Sales $983.000K

Benzinga·03/23/2026 22:08:03
Listen to the news
NRX Pharmaceuticals (NASDAQ:NRXP) reported quarterly earnings of $0.20 per share. This is a 125.97 percent increase over losses of $(0.77) per share from the same period last year. The company reported $983.000 thousand in sales this quarter.